StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research note issued to investors on Wednesday morning. The firm issued a sell rating on the stock.
Ampio Pharmaceuticals Stock Performance
NYSE AMPE opened at $0.00 on Wednesday. Ampio Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $0.70. The firm has a market capitalization of $2,383.50, a PE ratio of 0.00 and a beta of 3.73.
About Ampio Pharmaceuticals
See Also
- Five stocks we like better than Ampio Pharmaceuticals
- Breakout Stocks: What They Are and How to Identify Them
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- Investing In Preferred Stock vs. Common Stock
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
